These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22571192)

  • 1. Use of Flow Focusing® technology to produce tobramycin-loaded PLGA microparticles for pulmonary drug delivery.
    Martín-Banderas L; Holgado MA; Álvarez-Fuentes J; Fernández-Arévalo M
    Med Chem; 2012 Jul; 8(4):533-40. PubMed ID: 22571192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
    Keohane K; Brennan D; Galvin P; Griffin BT
    Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.
    Ungaro F; d'Angelo I; Miro A; La Rotonda MI; Quaglia F
    J Pharm Pharmacol; 2012 Sep; 64(9):1217-35. PubMed ID: 22881435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
    Sethuraman VV; Hickey AJ
    AAPS PharmSciTech; 2002; 3(4):E28. PubMed ID: 12916922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.
    Kumar G; Shafiq N; Malhotra S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(2):149-82. PubMed ID: 22475089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of PLGA nanoparticles.
    Astete CE; Sabliov CM
    J Biomater Sci Polym Ed; 2006; 17(3):247-89. PubMed ID: 16689015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation.
    Huang W; Zhang C
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28941234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step fabrication of agent-loaded biodegradable microspheroids for drug delivery and imaging applications.
    Heslinga MJ; Willis GM; Sobczynski DJ; Thompson AJ; Eniola-Adefeso O
    Colloids Surf B Biointerfaces; 2014 Apr; 116():55-62. PubMed ID: 24441181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles.
    Yoo J; Won YY
    ACS Biomater Sci Eng; 2020 Nov; 6(11):6053-6062. PubMed ID: 33449671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
    Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C
    J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and characterization of tetrandrine-loaded PLGA nanocomposite particles by premix membrane emulsification coupled with spray-drying method].
    Hu T; Zhu HX; Guo LW; Pan LM; Li B; Shi FY; Lu J
    Yao Xue Xue Bao; 2014 Nov; 49(11):1607-13. PubMed ID: 25757290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery.
    Xu Q; Hashimoto M; Dang TT; Hoare T; Kohane DS; Whitesides GM; Langer R; Anderson DG
    Small; 2009 Jul; 5(13):1575-81. PubMed ID: 19296563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization.
    Parumasivam T; Leung SS; Quan DH; Triccas JA; Britton WJ; Chan HK
    Eur J Pharm Sci; 2016 Jun; 88():1-11. PubMed ID: 27049049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
    Selvam P; El-Sherbiny IM; Smyth HD
    J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.